Gene · 1364
Papers3,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Breast implant associated anaplastic large cell lymphoma: Evidence for an efficient diagnostic workup. | Tumori | 2023 | 36942354 | PubTator, text mining | PubMed |
| Mean Nocturnal Baseline Impedance (MNBI) Provides Evidence for Standardized Management Algorithms of Nonacid Gastroesophageal Reflux-Induced Chronic Cough. | Int J Clin Pract | 2023 | 36941872 | PubTator, text mining | PubMed |
| CLDN6 inhibits breast cancer metastasis through WIP-dependent actin cytoskeleton-mediated autophagy. | J Exp Clin Cancer Res | 2023 | 36935496 | PubTator, text mining | PubMed |
| Hepatotoxicity of polymeric proanthocyanidins is caused by translocation of bacterial lipopolysaccharides through impaired gut epithelium. | Toxicol Lett | 2023 | 36935082 | PubTator, text mining | PubMed |
| Apical-Out Enteroids as an Innovative Model for Necrotizing Enterocolitis. | J Surg Res | 2023 | 36915002 | PubTator, text mining | PubMed |
| Interactions between microbiota and cervical epithelial, immune, and mucus barrier. | Front Cell Infect Microbiol | 2023 | 36909729 | PubTator, text mining | PubMed |
| Infantile human labial glands: Distribution of aquaporins and claudins in the context of paracellular and transcellular pathways. | Tissue Cell | 2023 | 36905859 | PubTator, text mining | PubMed |
| Long-Term Survival of More than 5 Years with Maintenance Therapy Using Single-Agent Pemetrexed in a Patient with Diffuse Malignant Peritoneal Mesothelioma. | Case Rep Med | 2023 | 36896044 | PubTator, text mining | PubMed |
| Preclinical Efficacy of the Antibody-Drug Conjugate CLDN6-23-ADC for the Treatment of CLDN6-Positive Solid Tumors. | Clin Cancer Res | 2023 | 36884217 | PubTator, text mining | PubMed |
| Chemical exposures and suspected impact on Gulf War Veterans. | Mil Med Res | 2023 | 36882803 | PubTator, text mining | PubMed |
| Visfatin increases the invasive potential of ovarian granulosa tumor spheroids by reprogramming glucose metabolism. | Reproduction | 2023 | 36880885 | PubTator, text mining | PubMed |
| Understanding disruption of the gut barrier during inflammation: Should we abandon traditional epithelial cell lines and switch to intestinal organoids? | Front Immunol | 2023 | 36875103 | PubTator, text mining | PubMed |
| Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis. | Signal Transduct Target Ther | 2023 | 36872368 | PubTator, text mining | PubMed |
| Intestinal Epithelial Digestive, Transport, and Barrier Protein Expression Is Increased in Environmental Enteric Dysfunction. | Lab Invest | 2023 | 36870290 | PubTator, text mining | PubMed |
| Serum Zonulin Levels as an Early Biomarker in Predicting the Severity and Complications of Acute Pancreatitis. | Eurasian J Med | 2023 | 36861872 | PubTator, text mining | PubMed |
| Multi-Omics Analyses Reveal the Mechanisms of Early Stage Kidney Toxicity by Diquat. | Toxics | 2023 | 36851058 | PubTator, text mining | PubMed |
| Galangin-Loaded Gold Nanoparticles: Molecular Mechanisms of Antiangiogenesis Properties in Breast Cancer. | Int J Breast Cancer | 2023 | 36844680 | PubTator, text mining | PubMed |
| An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma. | Cancer Sci | 2023 | 36840413 | PubTator, text mining | PubMed |
| Therapeutic Potential of Gut Microbiota and Its Metabolite Short-Chain Fatty Acids in Neonatal Necrotizing Enterocolitis. | Life (Basel) | 2023 | 36836917 | PubTator, text mining | PubMed |
| The Role of Tight Junctions in Atopic Dermatitis: A Systematic Review. | J Clin Med | 2023 | 36836073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1364/papers?page=28